The global medical thawing system market size reached US$ 205.5 Million in 2023. Looking forward, the publisher expects the market to reach US$ 372.8 Million by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2023-2032. The increasing prevalence of chronic diseases, the rising demand for regenerative and personalized medicines, and ongoing technological advancements represent some of the key factors driving the market.
A medical thawing system is used in healthcare facilities to thaw frozen biological specimens such as blood products, vaccines, and tissue samples safely and quickly. It employs a controlled process of heating and agitating the frozen specimen in a water bath, allowing it to thaw evenly without causing any damage to the sample. In addition to this, they help minimize the risk of contamination, ensure accurate and reliable test results, and reduce the risk of injury to healthcare workers handling frozen specimens. The medical thawing system meets strict regulatory standards for handling biological materials and is essential in ensuring the quality and efficacy of the thawed specimen. As a result, it is widely employed across various healthcare facilities as a reliable, efficient, and standardized device for ensuring the quality and efficacy of biological samples used in patient care and research.
2. What is the expected growth rate of the global medical thawing system market during 2024-2032?
3. What are the key factors driving the global medical thawing system market?
4. What has been the impact of COVID-19 on the global medical thawing system market?
5. What is the breakup of the global medical thawing system market based on the product type?
6. What is the breakup of the global medical thawing system market based on the sample type?
7. What is the breakup of the global medical thawing system market based on the end user?
8. What are the key regions in the global medical thawing system market?
9. Who are the key players/companies in the global medical thawing system market?
A medical thawing system is used in healthcare facilities to thaw frozen biological specimens such as blood products, vaccines, and tissue samples safely and quickly. It employs a controlled process of heating and agitating the frozen specimen in a water bath, allowing it to thaw evenly without causing any damage to the sample. In addition to this, they help minimize the risk of contamination, ensure accurate and reliable test results, and reduce the risk of injury to healthcare workers handling frozen specimens. The medical thawing system meets strict regulatory standards for handling biological materials and is essential in ensuring the quality and efficacy of the thawed specimen. As a result, it is widely employed across various healthcare facilities as a reliable, efficient, and standardized device for ensuring the quality and efficacy of biological samples used in patient care and research.
Medical Thawing System Market Trends:
The rising number of individuals suffering from chronic diseases and viral and bacterial infections is one of the primary factors driving the market growth. In line with this, the growing inclination toward organ transplantation and an increase in organ donors combined with the surging demand for blood transfusions is creating a favorable outlook for the market. In addition to this, the expanding demand for regenerative medicine is fuelling the need for safe and efficient thawing of stem cells, tissues, and other biological samples, which, in turn, is contributing to the market growth. Moreover, innovative technological advancements, such as the integration of automation and robotics technology to enhance the efficiency and accuracy of thawing systems, are presenting remunerative growth opportunities for the market. Furthermore, the outbreak of the COVID-19 virus has impelled the collection of tissue specimens for researching the biological impact of the infection and identifying new therapeutic interventions and prevention strategies, which is positively impacting the market growth. Other factors, such as the rising geriatric population, increasing healthcare expenditure, growing number of people participating in blood donation campaigns, the escalating demand for personalized medicines, and extensive investments in research and development (R&D) projects to develop effective therapies for treating rare diseases, are strengthening the market growth.Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global medical thawing system market report, along with forecasts at the global, regional and country level from 2024-2032. The report has categorized the market based on product type, sample type and end user.Product Type Insights:
- Manual
- Automated
Sample Type Insights:
- Blood
- Plasma
- Stem Cells
- Whole Blood
- Platelets
- Embryo
- Ovum
- Semen
End User Insights:
- Blood Banks
- Hospitals
- Tissue Banks
- Pharmaceutical and Biotech Companies
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global medical thawing system market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Barkey GmbH & Co. KG, Biolife Solutions Inc., Boekel Scientific, Cardinal Health Inc., General Electric Company, Helmer Scientific Inc., Hospicare Systems, labcold Limited, MMS Medical and Laboratory Supplies, Sarstedt AG & Co. KG, Sartorius AG, Terumo Penpol Private Limited (Terumo Corporation) and Thermo Fisher Scientific Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.Key Questions Answered in This Report
1. What was the size of the global medical thawing system market in 2023?2. What is the expected growth rate of the global medical thawing system market during 2024-2032?
3. What are the key factors driving the global medical thawing system market?
4. What has been the impact of COVID-19 on the global medical thawing system market?
5. What is the breakup of the global medical thawing system market based on the product type?
6. What is the breakup of the global medical thawing system market based on the sample type?
7. What is the breakup of the global medical thawing system market based on the end user?
8. What are the key regions in the global medical thawing system market?
9. Who are the key players/companies in the global medical thawing system market?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Medical Thawing System Market
6 Market Breakup by Product Type
7 Market Breakup by Sample Type
8 Market Breakup by End User
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Barkey GmbH & Co. KG
- Biolife Solutions Inc.
- Boekel Scientific
- Cardinal Health Inc.
- General Electric Company
- Helmer Scientific Inc.
- Hospicare Systems
- labcold Limited
- MMS Medical and Laboratory Supplies
- Sarstedt AG & Co. KG
- Sartorius AG
- Terumo Penpol Private Limited (Terumo Corporation) and Thermo Fisher Scientific Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 141 |
| Published | March 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 205.5 Million |
| Forecasted Market Value ( USD | $ 372.8 Million |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
